Compare CALC & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALC | LOCL |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 22.8M |
| IPO Year | 2020 | 2021 |
| Metric | CALC | LOCL |
|---|---|---|
| Price | $0.66 | $1.06 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 283.8K | 18.8K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $48,365,000.00 |
| Revenue This Year | N/A | $97.19 |
| Revenue Next Year | N/A | $33.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.82 |
| 52 Week Low | $0.46 | $0.95 |
| 52 Week High | $7.20 | $4.00 |
| Indicator | CALC | LOCL |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 47.06 |
| Support Level | $0.52 | $0.98 |
| Resistance Level | $0.77 | $1.22 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 17.08 | 44.96 |
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.